Skip to main content
SpringerLink
Log in

The Connection of Polymorphisms–238A/G TNF and Ile655Val HER2 Influences the Risk and Molecular Features of Breast Cancer

  • Experimental Works
  • Published:
Molecular Genetics, Microbiology and Virology Aims and scope Submit manuscript

Abstract

Inflammation and hormonal and growth factors play an important role in the development of breast cancer (BC). Genes TNF, ESR1, and HER2 have polymorphisms that affect the level of transcription or activity of their protein products. The objective was to evaluate the effect of functional polymorphisms of these genes on the clinical and molecular features of BC. The study included 140 patients with primary BC without distant metastases. The concentrations of serum sTNF were determined for 111 BC patients. Additionally, we used archival DNA samples with known genotype–238A/G TNF from BC patients and the control- group women. Polymorphisms–238G/A TNF,–308G/A TNF,–397C/T ESR1, and Ile655Val HER2 were determined by PCR. The analysis of the data revealed the connection of AG–238TNF genotype with the Luminal A molecular subtype of tumor. A synchronous decrease of the index of proliferation Ki67 and serum level of sTNF was noted for AG–238TNF and IleVal HER2 genotypes. At the same time, carriers of the AG–238TNF more often had IleVal HER2 genotype than did carriers of GG–238TNF (70 and 32%, respectively; p = 0.032). In general, the distribution of HER2 genotypes in carriers of the AG–238TNF BC patients differed from the GG–238TNF BC patients and from both genotypes (AG and GG–238TNF) of the control group. The dependence was confirmed on archived DNA samples from BC patients with AG–238TNF genotype. There was no connection of polymorphism 397C/T ESR1 with ER status of the tumor and no connection of polymorphism Ile655Val HER2 with overexpression and/or amplification of the cell receptor Her2. Thus, the polymorphism–238G/A TNF is associated with Ile655Val HER2 and affects the molecular characteristics of BC. It is suggested that the Val HER2 may be a risk factor for BC for carriers of the AG–238TNF genotype.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sostoyanie onkologicheskoi pomoshchi naseleniyu Rossii v 2015 godu (Cancer Care for the Population of Russia in 2015), Kaprin, A.D., Starinskiy, V.V., and Petrova, G.V., Eds., Moscow: P. Herzen Moscow Oncology Research Institute, 2016. http://www.oncology.ru/service/statistics/condition/. Accessed March 1, 2017.

  2. Waters, J.P., Pober, J.S., and Bradley, J.R., Tumour necrosis factor and cancer, J. Pathol., 2013, vol. 230, pp. 241–248. doi 10.1002/path.4188

    Article  CAS  PubMed  Google Scholar 

  3. Sonnenblick, A., Fumagalli, D., Sotiriou, Ch., and Piccart, M., Is the differentiation into molecular subtypes of breast cancer important for staging, local and systemic therapy, and follow up?, Cancer Treat. Rev., 2014, vol. 40, pp. 1089–1095. doi 10.1016/j.ctrv.2014.07.005

    Article  CAS  PubMed  Google Scholar 

  4. Weitzenfeld, P., Meron, N., Leibovich-Rivkin, T., Meshel, T., and Ben-Baruch, A., Progression of luminal breast tumors is promoted by ménage à trois between the inflammatory cytokine TNFα and the hormonal and growth-supporting arms of the tumor microenvironment, Mediators Inflammation, 2013, vol. 2013, p. 720536. doi 10.1155/2013/720536

    Article  Google Scholar 

  5. Simpson, P.D., Moysi, E., Wicks, K., Sudan, K., Rowland-Jones, S.L., McMichael, A.J., et al., Functional differences exist between TNFα promoters encoding the common–237G SNP and the rarer HLA-B*5701-linked A variant, PLoS One, 2012, vol. 7, no. 7, p. e40100. doi 10.1371/journal.pone.0040100

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Karimi, M., Goldie, L.C., Cruickshank, M.N., Moses, E.K., and Abraham, L.J., A critical assessment of the factors affecting reporter gene assays for promoter SNP function: a reassessment of–308TNF polymorphism function using a novel integrated reporter system, Eur. J. Hum. Genet., 2009, vol. 17, pp. 1454–1462. doi 10.1038/ejhg.2009.80

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Weickert, C.S., Miranda-Angulo, A.L., Wong, J., Perlman, W.R., Ward, S.E., Radhakrishna, V., et al., Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia, Hum. Mol. Genet., 2008, vol. 17, no. 5, pp. 2293–2309. doi 10.1093/hmg/ddn130

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Fleishman, S.J., Schlessinger, J., and Ben-Tal, N., A putative molecular-activation switch in the transmembrane domain of erbB2, Proc. Natl. Acad. Sci. U.S.A., 2002, vol. 99, no. 25, pp. 15937–15940.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Guo, J., Meng, H., Pei, J., and Zhu, M., Association between the TNF-α–238G> A and TGF-b1L10P polymorphisms and breast cancer risk: A meta-analysis, Breast Care, 2011, vol. 6, pp. 126–129. doi 10.1159/000327515

    Article  PubMed  PubMed Central  Google Scholar 

  10. Fang, F., Yao, L., Yu, X.J., Yu, L., Wu, Q., and Yu, L., TNFα 2308G/A polymorphism is associated with breast cancer risk: A meta-analysis involving 10184 cases and 12911 controls, Breast Cancer Res. Treat., 2010, vol. 122, no. 1, pp. 267–271. doi 10.1007/s10549-009-0698-1

    Article  CAS  PubMed  Google Scholar 

  11. Chen, W., Yang, H., Tang, W.-R., Feng, Sh.-J., and Wei, Y.-L., Updated meta-analysis on HER2 polymorphisms and risk of breast cancer: Evidence from 32 studies, Asian Pac. J. Cancer Prev., 2014, vol. 15, no. 22, pp. 9643–9647. http://dx.doi.org/. doi 10.7314/APJCP.2014.15.22.9643. http://dx.doi.org/10.7314/APJCP.2014.15.22.9643.

    Article  PubMed  Google Scholar 

  12. Zhang, Y., Zhang, M., Yuan, X., Zhang, Z., Zhang, P., Chao, H., et al., Association between ESR1PvuII, XbaI, and P325P polymorphisms and breast cancer susceptibility: A meta-analysis, Med. Sci. Monit., 2015, vol. 21, pp. 2986–2996. doi 10.12659/MsM.894010

    Google Scholar 

  13. Malivanova, T.F., Skoromyslova, E.V., Yurchenko, V.A., Kononenko, I.B., Manzyuk, L.V., and Mazurenko, N.N., Analysis of the–238(G/A)TNF polymorphism in breastcancer patients, Mol. Genet., Microbiol. Virol., 2013, vol. 28, no. 2, pp. 52–55. doi 10.3103/S0891416813020031

    Article  Google Scholar 

  14. Taneja, P., Maglic, D., Kai, F., Zhu, S., Kendig, R.D., Fry, E.A., and Inoue, K., Classical and novel prognostic markers for breast cancer and their clinical significance, Clin. Med. Insights: Oncol., 2010, vol. 4, pp. 15–34. doi 10.4137/CMo.s4773

    CAS  Google Scholar 

  15. Papadopoulou, E., Tripsianis, G., Anagnostopoulos, K., Tentes, I., Kakolyris, S., Galazios, G., et al., Significance of serum tumor necrosis factor-alpha and its combination with HER-2 codon 655 polymorphism in the diagnosis and prognosis of breast cancer, Int. J. Biol. Markers, 2010, vol. 25, no. 3, pp. 126–135. https://www.ncbi. nlm.nih.gov/pubmed/20872355. Accessed March 1, 2017.

    Article  CAS  PubMed  Google Scholar 

  16. Rupasree, Y., Naushad, S.M., Rajasekhar, L., Uma, A., and Kutala, V.K., Association of estrogen receptor 1 (ESR1) haplotypes with risk for systemic lupus erythematosus among South Indians, Indian J. Exp. Biol., 2015, vol. 53, no. 11, pp. 714–718. https://www.ncbi. nlm.nih.gov/pubmed/26669013. Accessed March 1, 2017.

    PubMed  Google Scholar 

  17. Ryba-Stanisławowska, M., Rybarczyk-Kapturska, K., Brandt, A., Myśliwiec, M., and Myśliwska, J., IVS1–397T>C estrogen receptor α polymorphism is associated with low-grade systemic inflammatory response in type 1 diabetic girls, Mediators Inflammation, 2014, vol. 2014, p. 839585. doi 10.1155/2014/839585

    Google Scholar 

  18. Kroeger, K.M., Steer, J.H., Joyce, D.A., and Abraham, L.J., Effects of stimulus and cell type on the expression of the–308 tumour necrosis factor promoter polymorphism, Cytokine, 2000, vol. 12, no. 2, pp. 110–119. doi 10.1006/cyto.1999.0529

    Article  CAS  PubMed  Google Scholar 

  19. Gupta, R., Kapuria, V., and Das, S.N., Single nucleotide polymorphisms in TNF-alpha, TNFR2 gene and TNF-alpha production in Asian Indians, Immunol. Invest., 2009, vol. 38, nos. 3–4, pp. 240–254. doi 10.1080/08820130902766563

    CAS  PubMed  Google Scholar 

  20. Mekinian, A., Tamouza, R., Pavy, S., Gestermann, N., Ittah, M., Mariette, X., and Miceli-Richard, C., Functional study of TNF-α promoter polymorphisms: literature review and meta-analysis, Eur. Cytokine Network, 2011, vol. 22, no. 2, pp. 88–102. doi 10.1684/ecn.2011.0285

    CAS  Google Scholar 

  21. Kaluza, W., Reuss, E., Grossmann, S., Hug, R., Schopf, R.E., Galle, P.R., et al., Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism, J. Invest. Dermatol., 2000, vol. 114, no. 6, pp. 1180–1183. doi 10.1046/j.1523-1747.2000.00001.x

    Article  CAS  PubMed  Google Scholar 

  22. Hasson, S.P., Rubinek, T., Ryvo, L., and Wolf, I., Endocrine resistance in breast cancer: focus on the phosphatidylinositol 3-kinase/akt/mammalian target of rapamycin signaling pathway, Breast Care (Basel, Switz.), 2013, vol. 8, no. 4, pp. 248–255. doi 10.1159/000354757

    Article  Google Scholar 

  23. Han, X., Diao, L., Xu, Y., Xue, W., Ouyang, T., Li, J., et al., Association between the HER2Ile655Val polymorphism and response to trastuzumab in women with operable primary breast cancer, Ann. Oncol., 2014, vol. 25, no. 6, pp. 1158–1164. doi 10.1093/annonc/mdu111

    Article  CAS  PubMed  Google Scholar 

  24. Bustreo, S., Osella-Abate, S., Cassoni, P., Donadio, M., Airoldi, M., Pedani, F., et al., Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: A large case series study with a long-term follow-up, Breast Cancer Res. Treat., 2016, vol. 157, no. 2, pp. 363–371. doi 10.1007/s10549-016-3817-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Wang, X.H., Hong, X., Zhu, L., Wang, Y.T., Bao, J.P., Liu, L., et al., Tumor necrosis factor alpha promotes the proliferation of human nucleus pulposus cells via nuclear factor-κB, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase, Exp. Biol. Med. (Maywood), 2015, vol. 240, no. 4, pp. 411–417. doi 10.1177/1535370214554533

    Article  CAS  Google Scholar 

  26. Tsianakas, A., Brunner, P.M., Ghoreschi, K., Berger, C., Loser, K., Röcken, M., et al., The single-chain anti-TNF-α antibody DLX105 induces clinical and biomarker responses upon local administration in patients with chronic plaque-type psoriasis, Exp. Dermatol., 2016, vol. 25, no. 6, pp. 428–433. doi 10.1111/exd.12927

    Article  CAS  PubMed  Google Scholar 

  27. Erdem, H., Gundogdu, B., Ankarali, H., Yasar, M., Sener, E., Oktay, M., et al., Correlation of astrocyte elevated gene-1, basic-fibroblast growth factor, betacatenin, Ki-67, tumor necrosis factor-alfa with prognostic parameters in ductal carcinomas and ductal intraepithelial neoplasms, Niger. J. Clin. Pract., 2015, vol. 18, no. 5, pp. 638–643. doi 10.4103/1119-3077.158961

    CAS  PubMed  Google Scholar 

  28. Pooja, S., Francis, A., Bid, H.K., Kumar, S., Rajender, S., Ramalingam, K., et al., Role of ethnic variations in TNF-α and TNF-β polymorphisms and risk of breast cancer in India, Breast Cancer Res. Treat., 2011, vol. 126, no. 3, pp. 739–747. doi 10.1007/s10549-010-1175-6

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, 115211, Russia

    T. F. Malivanova & N. N. Mazurenko

  2. State Research Center Burnasyan Federal Medical Biophysical Center, Federal Medical Biological Agency, Moscow, 123182, Russia

    A. S. Ostashkin

Authors
  1. T. F. Malivanova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. S. Ostashkin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. N. Mazurenko
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. F. Malivanova.

Additional information

Original Russian Text © T.F. Malivanova, A.S. Ostashkin, N.N. Mazurenko, 2017, published in Molekulyarnaya Genetika, Mikrobiologiya i Virusologiya, 2017, No. 3, pp. 92–97.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Malivanova, T.F., Ostashkin, A.S. & Mazurenko, N.N. The Connection of Polymorphisms–238A/G TNF and Ile655Val HER2 Influences the Risk and Molecular Features of Breast Cancer. Mol. Genet. Microbiol. Virol. 32, 141–147 (2017). https://doi.org/10.3103/S0891416817030053

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.3103/S0891416817030053

Keywords

Search

Navigation